Bober, B.; Saracyn, M.; Zaręba, K.; Lubas, A.; Mazurkiewicz, P.; Wilińska, E.; Kamiński, G.
Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms—A Preliminary Study. J. Clin. Med. 2022, 11, 919.
https://doi.org/10.3390/jcm11040919
AMA Style
Bober B, Saracyn M, Zaręba K, Lubas A, Mazurkiewicz P, Wilińska E, Kamiński G.
Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms—A Preliminary Study. Journal of Clinical Medicine. 2022; 11(4):919.
https://doi.org/10.3390/jcm11040919
Chicago/Turabian Style
Bober, Barbara, Marek Saracyn, Kornelia Zaręba, Arkadiusz Lubas, Paweł Mazurkiewicz, Ewelina Wilińska, and Grzegorz Kamiński.
2022. "Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms—A Preliminary Study" Journal of Clinical Medicine 11, no. 4: 919.
https://doi.org/10.3390/jcm11040919
APA Style
Bober, B., Saracyn, M., Zaręba, K., Lubas, A., Mazurkiewicz, P., Wilińska, E., & Kamiński, G.
(2022). Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms—A Preliminary Study. Journal of Clinical Medicine, 11(4), 919.
https://doi.org/10.3390/jcm11040919
